Medtronic Unveils AiBLE™ Intelligent Neurosurgery Ecosystem Solution for High-Quality Development

Recently, at the “Creating a New Ecosystem for Neurosurgery” themed launch conference, Medtronic officially announced the successful launch of its Stealth Autoguide™ neurosurgery robot in China, along with the introduction of its unique AiBLE™ intelligent neurosurgery ecosystem solution, aiming to set a new industry benchmark and accelerate the entry of China’s neurosurgery into the intelligent era, creating a new chapter for high-quality development.Professor Mao Ying, Director of Huashan Hospital affiliated with Fudan University, Professor Stefan Wolfsberger from the Medical University of Graz, Austria, Professor Yu Yanbing, Director of Neurosurgery at the China-Japan Friendship Hospital, Professor Xiao Xinru from Xuanwu Hospital of Capital Medical University, and Ms. Yu Jing, Vice President of Medtronic and General Manager of the Orthopedic and Neurosurgery Business Group in China, along with other industry experts, engaged in multidimensional discussions on the current opportunities and challenges in the field of neurosurgery, industry trends, and the value of intelligent neurosurgery ecosystem solutions, providing new ideas for the future exploration of intelligent neurosurgery.Medtronic Unveils AiBLE™ Intelligent Neurosurgery Ecosystem Solution for High-Quality DevelopmentLaunch ceremony of Medtronic’s AiBLE™ intelligent neurosurgery ecosystem solution

Collaborate and Build Together, Creating a New Ecosystem for Intelligent Neurosurgery Development

With the rapid economic development and the increasing aging population, the incidence and detection rates of neurological diseases in China are rising year by year. Given the diverse types of neurological diseases, their severity, complexity, and significant differences in prognosis, the increasing payment levels of residents and the rapid advancements in medical technology have led more patients to be willing to undergo surgical treatment. This not only raises higher demands for surgical equipment but also stimulates a continuously growing demand for high-quality medical care. Meanwhile, neurosurgery requires precision, minimally invasive techniques, and high efficiency, as it operates around the brain, the “command center” of the human body, where the cranial space is limited, and the structures of important tissue areas are intricate and complex. Once damaged, repair and regeneration are difficult, affecting the quality of life of patients. Therefore, neurosurgery is often referred to as the “crown jewel” of surgical procedures.With the continuous popularization and iteration of innovative technologies such as big data, artificial intelligence, and cloud computing in the medical field, high-precision neurosurgical equipment represented by intelligent surgical robots is propelling China’s neurosurgery into a new era of digitalization and intelligence. However, in clinical applications, most intelligent surgical devices still exhibit phenomena such as “data islands,” which greatly affect diagnostic and treatment outcomes as well as surgical efficiency. Therefore, how to build a diverse and integrated intelligent neurosurgery ecosystem that connects medical scenarios, interlinks device data, and connects industrial value has become a new focus and direction for exploration across various sectors.Medtronic Unveils AiBLE™ Intelligent Neurosurgery Ecosystem Solution for High-Quality DevelopmentProfessor Mao Ying, Director of Huashan Hospital affiliated with Fudan University said, “Neuroscience is entering an era led by intelligence, which will further unleash the infinite potential of digitalization and intelligence in medical scenarios, providing new development opportunities for neurosurgery.” Professor Mao Ying believes that “the innovation and iteration of intelligent devices will empower precise neurosurgery to enter a new era.” As a pioneer in global medical technology, services, and solutions, Medtronic’s Stealth Autoguide™ neurosurgery robot not only redefines neurosurgery robots through three dimensions: intelligent precision, full visibility, and seamless integration, but also completes the Medtronic AiBLE™ intelligent neurosurgery ecosystem solution.The AiBLE™ intelligent neurosurgery ecosystem solution, which includes Stealth Autoguide™, features three main characteristics: interconnectivity, collaborative benefits, and open compatibility, enabling data interconnection among various intelligent devices within the ecosystem, integrating diagnosis, treatment, and follow-up into a one-stop decision support data system for neurosurgery. On this basis, the collaboration among devices within the ecosystem maximizes their respective advantages while breaking the limitations of existing device islands, achieving 1+1>2, and building a personalized technology platform for different sub-specialty diseases and surgical procedures to meet the needs of various sub-specialty surgeries. Additionally, it can be open and compatible with commonly used intelligent devices in neurosurgery such as microscopes, endoscopes, ultrasound, CT, MR, and electrophysiology, guiding surgical implementation through multi-data integration, and providing more possibilities for the future development of AiBLE™ intelligent neurosurgery ecosystem-linked products, services, and collaborations with upstream and downstream partners.

Strategic Planning and Empowerment, Fully Supporting High-Quality Development of Intelligent Neurosurgery

This year marks the beginning of China’s 14th Five-Year Plan, with the national innovation drive and the “Healthy China 2030” strategy continuing to deepen, presenting new opportunities for high-quality development in intelligent neurosurgery. The launch of the AiBLE™ intelligent neurosurgery ecosystem solution is another in-depth exploration by Medtronic to deepen its commitment to China and work with the industry to accelerate the development of intelligent neurosurgery.On one hand, cutting-edge intelligent medical technology will help improve the diagnosis and treatment levels of neurosurgical diseases, making quality medical services more accessible. On the other hand, the AiBLE™ intelligent neurosurgery ecosystem solution can help shorten the learning curve for young doctors, support the construction of sub-specialty teams and disciplines in hospitals, and better assist hospitals in organically integrating existing advantageous resources and equipment, thereby enhancing overall medical service efficiency and effectiveness, ultimately benefiting patients.Moreover, Medtronic, using the AiBLE™ intelligent neurosurgery ecosystem solution as a starting point, anchors on industry transformation and unmet needs, focusing on four dimensions: products, services, academia-industry collaboration, and the industry, continuously building and optimizing a comprehensive ecosystem in the field of neurosurgery. In addition to striving to create an interconnected product ecosystem, Medtronic relies on its two innovation centers in Chengdu and Shanghai to continuously improve high-quality professional education and a complete clinical service system, thereby enhancing the diagnostic capabilities of Chinese neurosurgeons and their ability to explore complex procedures, increasing the accessibility and penetration of advantageous medical resources.In the context of the major trend of “industry-medical integration” and “medical-engineering transformation,” Medtronic recently reached a strategic cooperation with Huashan Hospital, a national center for neurological diseases, to jointly build an “Innovation Platform for Industry-Medical Integration in Neuroscience,” creating another innovative benchmark for the collaborative model of “industry-academia-research-medical practice.” In the future, Medtronic will continue to collaborate with more upstream and downstream industry partners to expand the connotation of the local innovation industry chain, helping China’s intelligent neurosurgery enter the “fast lane” of high-quality development.Medtronic Unveils AiBLE™ Intelligent Neurosurgery Ecosystem Solution for High-Quality DevelopmentMs. Yu Jing, Vice President of Medtronic and General Manager of the Orthopedic and Neurosurgery Business Group in China stated, “Neuroscience has always been a vast universe that humanity continuously explores and refines. Its vast space requires our endless exploration, and the future of intelligent neurosurgery also needs us to constantly break through the boundaries of science and ecology, as technology coexists with health.” Ms. Yu Jing expressed, “In the future, Medtronic will continue to deepen its commitment to intelligent neurosurgery, further enrich intelligent medical solutions, fully unleash their multidimensional value, and work with various partners to continuously expand the boundaries of the ecosystem, co-creating a new chapter in the high-quality development of intelligent neurosurgery.”· END ·

–Video Highlights–

▲ Possible breakthrough directions in cancer treatment over the next decade

–Exciting Recommendations–Medtronic Unveils AiBLE™ Intelligent Neurosurgery Ecosystem Solution for High-Quality Development

Medtronic Unveils AiBLE™ Intelligent Neurosurgery Ecosystem Solution for High-Quality Development

Pharmaceutical | Biopharmaceutical | ADC | mRNA | CAR-T | PD-1 | Medical Devices | Imaging | IVD | Cardiovascular | Orthopedics | Oral | Ophthalmology | Surgical Robots | Internet Medical | Hospitals | CXO | Life Sciences

In-depth Original | Annual Review | Trend Analysis | Cycle-Crossing Series | Stock Market Dynamics | Corporate Dynamics | Executive Dynamics | Pharmaceutical Financial Reports | Medical Device Financial Reports | Major Mergers | Strategic Spin-offs | Executive Interviews | Compensation | Policy Analysis | Medical Insurance Negotiation | DRG/DIP | Centralized Procurement | JPM | Latest News | Import Expo | CMEF

Medical Device Rankings | Medtronic | Abbott | Johnson & Johnson Medical | Siemens Healthineers | BD | Stryker | GE Healthcare | Roche Diagnostics | Philips | Boston Scientific | Mindray | United Imaging | MicroPort Medical | Lepu Medical | Weigao | Danaher | Thermo Fisher

Pharmaceutical Rankings | Pfizer | AbbVie | Roche Pharmaceuticals | Johnson & Johnson Pharmaceuticals | Merck | AstraZeneca | Bristol-Myers Squibb | Sanofi | Novartis | GlaxoSmithKline | Heng Rui | BeiGene | Shijiazhuang Pharmaceutical | Innovent Biologics | Legend Biotech | Tianjing Biopharmaceutical | CStone Pharmaceuticals | Rongchang Biologics | Zai Lab | WuXi AppTec | Qiming Venture Partners | Liangshan Asia

As tides rise and fall, who is your outstanding employer in the health sector in 2023?Scan the QR code below to participate in the survey immediately,and receive an exclusive red envelope!☟☟☟Your participation will contribute to a donation for a public welfare project for childhood cancer in China!Medtronic Unveils AiBLE™ Intelligent Neurosurgery Ecosystem Solution for High-Quality DevelopmentCreating is not easy, please share, view, and liketo energize the medical trend↓

Leave a Comment